Hemlibra (emicizumab-kxwh) safely supports joint health in children with hemophilia A without inhibitors through three years ...
A high-throughput proteomics study of newborn dried blood spots uncovered a three-protein biomarker panel that distinguished ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback